Sign Up Today and Learn More About Zenith Epigenetics Stock
Invest in or calculate the value of your shares in Zenith Epigenetics or other pre-IPO companies through EquityZen's platform.
Zenith Epigenetics Stock (ZEEP)
Zenith Epigenetics Corp. is a research and development biotechnology company focused on new and innovative drugs by leveraging its
About Zenith Epigenetics Stock
Founded
2013
Total Funding
16.6M
Industries
Science and Engineering, Health Care, Biotechnology
Zenith Epigenetics Press Mentions
Stay in the know about the latest news on Zenith Epigenetics
Method of manufacturing a solid form of a bet bromodomain inhibitor
patents • Apr 03, 2025
Methods for treating triple-negative breast cancer in pre-selected patient …
patents • Apr 15, 2024
Epigenetics Market worth $7.63 billion by 2030, growing at a CAGR of 10.82% - Exclusive Report by 360iResearch
openpr • Mar 04, 2024
Zenith Epigenetics Proudly Supports Rare Disease Day
finance • Mar 04, 2024
Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
finance • Mar 04, 2024
Zenith Epigenetics Management
Leadership team at Zenith Epigenetics
Chief Business Officer
Sanjay Lakhotia
President and CEO
Donald McCaffrey
Join now and verify your accreditation status to gain access to:
- Zenith Epigenetics Current Valuation
- Zenith Epigenetics Stock Price
- Zenith Epigenetics Management
- Available deals in Zenith Epigenetics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Zenith Epigenetics Cap Table and Funding History by Share Class and Liquidity Preferences
- Zenith Epigenetics Revenue and Financials
- Zenith Epigenetics Highlights
- Zenith Epigenetics Business Model
- Zenith Epigenetics Risk Factors
- Zenith Epigenetics Research Report from SACRA Research
Trading Zenith Epigenetics Stock
How to invest in Zenith Epigenetics stock?
Accredited investors can buy pre-IPO stock in companies like Zenith Epigenetics through EquityZen funds. These investments are made available by existing Zenith Epigenetics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Zenith Epigenetics stock?
Shareholders can sell their Zenith Epigenetics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
